Home › Crohn's Disease › South Dakota
Crohn's Disease clinical trials in South Dakota
4 studies for Crohn's Disease are looking for participants at sites in South Dakota.
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Sanford Center for Digestive Health, Sioux Falls
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Sep 30, 2026 · NCT06581328A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Sanford USD Medical Center ( Site 5129), Sioux Falls
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Sep 29, 2026 · NCT06430801A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Sanford Health Research, Rapid City
RecruitingPhase 4
Ages 18 to 70 · All sexes · Updated Sep 9, 2026 · NCT06045754Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Rapid City Medical Center, LLC, Rapid City
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Apr 27, 2026 · NCT06456593From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.